Following ADAR1 Partners?
Get the free weekly contract digest
The latest new contracts, like ADAR1 Partners’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Adar1 Partners Increases Stake in Keros Therapeutics with $9.1M Purchase
Apr 12, 2025•about 1 year ago
Contract Type
partnership
AustinHedge FundDescription
Adar1 Partners, LP, a significant stakeholder in Keros Therapeutics, Inc. (NASDAQ:), has increased its stake in Keros Therapeutics with a $9.1 million purchase, acquiring a total of 939,698 shares of Keros Therapeutics’ common stock. The investment reflects ADAR1’s continued confidence in Keros, a pharmaceutical company engaged in the development of novel treatments for hematologic and musculoskeletal disorders.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months